Verastem Oncology Appoints Michael P. Bailey to its Board of Directors
Verastem Oncology appointed Michael P. Bailey to its Board of Directors, effective immediately. Bailey is currently the CEO of AVEO Pharmaceuticals, an LG Chem company, and brings over three decades of experience in global pharmaceutical and biotechnology leadership.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.